Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies

Most patients with chronic hepatitis C virus (HCV) genotype 1 infection who have had a previous null response (<2-log(10) reduction in HCV RNA by treatment week 12) to peginterferon/ribavirin (PegIFN/RBV) do not achieve a sustained virological response (SVR) when re-treated with a first-generatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wedemeyer, Heiner, Forns, Xavier, Hézode, Christophe, Lee, Samuel S., Scalori, Astrid, Voulgari, Athina, Le Pogam, Sophie, Nájera, Isabel, Thommes, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713467/
https://www.ncbi.nlm.nih.gov/pubmed/26752189
http://dx.doi.org/10.1371/journal.pone.0145409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713467/
https://www.ncbi.nlm.nih.gov/pubmed/26752189
http://dx.doi.org/10.1371/journal.pone.0145409

Ejemplares similares